Reshma Kewalramani - 24 Jun 2022 Form 4/A - Amendment Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
CEO & President, Director
Signature
/s/ Joy Liu, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
24 Jun 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
21 Jul 2022, 16:45
Date Of Original Report
28 Jun 2022
Previous filing
13 Jun 2022
Next filing
17 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VRTX Common Stock 111K 24 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Form 4 filed by Dr. Kewalramani on June 28, 2022 inadvertently excluded 134 shares acquired by Dr. Kewalramani under the issuer's Employee Stock Purchase Plan. This amendment reports all of the shares beneficially owned by Dr. Kewalramani following the transactions reported on the original Form 4.